Autism Impact Fund (AIF) is a venture and growth capital investment firm dedicated to revolutionizing the treatment of behavioral health, mental health, and complex chronic conditions, with a specific focus on autism and related neurodevelopmental disorders. AIF invests in scalable businesses that aim to improve the lives of individuals with ASD and similar conditions. The fund targets market venture capital returns by identifying unmet needs across the autism spectrum and deploying capital to fuel innovative solutions. Their portfolio includes companies focused on diagnostics, treatments, and lifelong support, spanning life sciences and data/tech-enabled services. AIF has closed a $60 million first fund and is actively investing in companies that move the needle in how these conditions are diagnosed, treated, and managed.
B2B / B2C
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Christopher MaleCo-Founder & Managing Partner
- Robert SarrazinChief Investment Officer & Managing Partner
- Lauren IngramPrincipal
How to reach them
Notable investments
Axial Therapeutics, Floreo, Camber Health, Jaguar Gene Therapy, Imagine Pediatrics, Spectrum AI, Joshin